T-cell priming with Deep IL-15 improves preclinical safety compared to systemic IL-15, and increases in vivo persistence and activity

被引：0
|
作者：
Geretti, Elena [1 ]
Bardwell, Philip [1 ]
Liang, Xiaoyan [1 ]
Caruso, Santina [1 ]
Chang, De-Kuan [1 ]
Lyons, Jesse [1 ]
Boesch, Austin [1 ]
Handler, Aaron [1 ]
Tassa, Carlos [1 ]
Bilic, Sanela [1 ]
Lancita, Janice [1 ]
Hawes, Becker [1 ]
Fitzgerald, Jonathan [1 ]
Andresen, Thomas [1 ]
机构：
[1] Torque Therapeut, Cambridge, MA USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A188
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A MEMBRANE-TETHERED IL-15/IL-15 RECEPTOR FUSION PROTEIN ENHANCES THE PERSISTENCE AND EFFICACY OF CD70-TARGETED TRUC-T CELLS
    Ding, Jian
    Webb, Lindsay
    Patterson, Troy
    Fleury, Michelle
    Zieba, Adam
    Horton, Holly
    Hofmeister, Robert
    Gutierrez, Dario
    Tighe, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A214 - A214
  • [32] In vivo treatment with IL-15 increases CD8+ T cell number in SIV-infected primates
    Mueller, YM
    Petrovas, C
    Bojczuk, PM
    Dimitriou, LD
    Beer, B
    Silvera, P
    Villinger, F
    Cairns, JS
    Lewis, MG
    Katsikis, PD
    FASEB JOURNAL, 2004, 18 (04): : A92 - A92
  • [33] IL-29 IL-10, IL-15 and TNF are key regulators of murine T-cell lymphoma growth
    Gravisaco, MJ
    Mongini, C
    Alvarez, E
    Ruybal, P
    Escalada, A
    Sanchez-Lockhart, M
    Hajos, S
    Waldner, C
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (04) : 627 - 632
  • [34] Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor α Chain Foster Local Environment for Type 1 Innate Like T Cell Development
    Tao, Huishan
    Li, Lei
    Liao, Nan-Shih
    Schluns, Kimberly S.
    Luckhart, Shirley
    Sleasman, John W.
    Zhong, Xiao-Ping
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [35] Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis
    Rowley, Jesse
    Monie, Archana
    Hung, Chien-Fu
    Wu, T. -C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (02) : 491 - 506
  • [36] Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15
    Wysocka, M
    Benoit, BM
    Newton, S
    Azzoni, L
    Montaner, LJ
    Rook, AH
    BLOOD, 2004, 104 (13) : 4142 - 4149
  • [37] BCMA-TARGETING CAR-T CELLS EXPANDED IN IL-15 HAVE AN IMPROVED PHENOTYPE FOR THERAPEUTIC USE COMPARED TO THOSE GROWN IN IL-2 OR IL-15/IL-7
    Battram, Anthony
    Bachiller, Mireia
    Urbano-Ispizua, Alvaro
    Martin-Antonio, Beatriz
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A65 - A65
  • [38] IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine
    Calarota, Sandra A.
    Dai, Anlan
    Trocio, Jeffrey N.
    Weiner, David B.
    Lori, Franco
    Lisziewicz, Julianna
    VACCINE, 2008, 26 (40) : 5188 - 5195
  • [39] IL-15, A NOVEL T-CELL GROWTH-FACTOR THAT SHARES ACTIVITIES AND RECEPTOR COMPONENTS WITH IL-2
    GIRI, JG
    ANDERSON, DM
    KUMAKI, S
    PARK, LS
    GRABSTEIN, KH
    COSMAN, D
    JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) : 763 - 766
  • [40] MECHANISM, CONSEQUENCES AND THERAPEUTIC TARGETING OF ABNORMAL IL-15 SIGNALING IN CUTANEOUS T-CELL LYMPHOMA
    Mishra, A.
    LaPerle, K.
    Kwiatkowski, S.
    Sullivan, L.
    Sams, G.
    Johns, J.
    Curphey, D.
    Wen, J.
    McConnell, K.
    Qi, J.
    Wong, H.
    Russo, G.
    Zhang, J.
    Marcucci, G.
    Bradner, J.
    Porcu, P.
    Caligiuri, M.
    HAEMATOLOGICA, 2016, 101 : 567 - 567
12345